Human retinal microglia express candidate receptors for HIV-1 infection
Background/aims: Microglia are the primary antigen presenting cells in the central nervous system and the retina, and can harbour viral antigens that may damage neural tissue via the release of neurotoxins. All cells bearing CD4 molecules and co-receptors (members of the chemokine receptor and Fcγ r...
Saved in:
Published in: | British journal of ophthalmology Vol. 89; no. 6; pp. 753 - 757 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01-06-2005
BMJ BMJ Publishing Group LTD Copyright 2005 British Journal of Ophthalmology |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background/aims: Microglia are the primary antigen presenting cells in the central nervous system and the retina, and can harbour viral antigens that may damage neural tissue via the release of neurotoxins. All cells bearing CD4 molecules and co-receptors (members of the chemokine receptor and Fcγ receptor families) are potential targets for the human immunodeficiency virus (HIV). In this study, retinal microglia (in vitro and in situ) were investigated for the expression of candidate HIV-1 binding receptors. Methods: Cultured human retinal microglia and frozen sections of human retinas were used. Immunohistochemistry was used to investigate expression of cell surface receptors necessary for HIV-1 infection: CD4, CC chemokine receptor 5 (CCR5), and Fcγ receptors. Results: Human retinal microglia expressed detectable levels of CD4, CD16, CD64, and CCR5 in vitro and Fcγ receptor I (CD64) in situ. Conclusions: Human retinal microglia express several candidate receptors required for viral binding and as such may be a potential reservoir for HIV-1 infection. |
---|---|
Bibliography: | ark:/67375/NVC-SJVRQV26-V Correspondence to: Dr Michele C Madigan Save Sight Institute, GPO Box 4337, Sydney NSW 2001 Australia; michele@eye.usyd.edu.au href:bjophthalmol-89-753.pdf istex:91662E5FE5BAC859CFA01C219C19CD993D2F9051 local:0890753 PMID:15923514 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Competing interests: None of the authors have any financial or commercial conflict of interest. Correspondence to: Dr Michele C Madigan Save Sight Institute, GPO Box 4337, Sydney NSW 2001 Australia; michele@eye.usyd.edu.au |
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjo.2004.057828 |